|
26 Nov 2008 |
Ceregene Announces Clinical Data from Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
|
|
21 Nov 2008 |
Aastrom Announces Treatment of First Patient in U.S. Phase II IMPACT-DCM Trial
|
|
20 Nov 2008 |
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
|
|
20 Nov 2008 |
Aldagen Announces Positive Phase 1/2 Results for Critical Limb Ischemia Stem Cell Therapy ALD-301
|
|
19 Nov 2008 |
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel(R) in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings
|
|
19 Nov 2008 |
Genvec Announces Intrim Survival Data in Pivotal Trial of TNFERADE(TM) in Locally Advanced Pancreatic Cancer
|
|
17 Nov 2008 |
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
|
|
13 Nov 2008 |
ZaBeCor's Investigational New Drug Application Approved by the FDA
|
|
11 Nov 2008 |
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
|
